Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: Future therapeutic targets

被引:43
作者
Kraneveld, Aletta D. [1 ]
Rijnierse, Anneke [2 ]
Nijkamp, Frans P. [1 ]
Garssen, Johan [1 ]
机构
[1] Univ Utrecht, Div Pharmacol & Pathophysiol, Utrecht Inst Pharmaceut Sci, Fac Sci, NL-3508 TB Utrecht, Netherlands
[2] Wageningen Univ, Nutr Metab & Genom Grp, Div Human Nutr, Wageningen, Netherlands
关键词
inflammatory bowel disease; irritable bowel syndrome; neuro-immune interaction; NANC nerve; cytokine; chemokine; Toll-like receptor; immunoglobulin;
D O I
10.1016/j.ejphar.2008.02.095
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The gastro-intestinal tract is well known for its largest neural network outside the central nervous system and for the most extensive immune system in the body. Research in neurogastroenterology implicates the involvement of both enteric nervous system and immune system in symptoms of inflammatory bowel disease and irritable bowel syndrome. Since both disorders are associated with increased immune cell numbers, nerve growth and activation of both immune cells and nerves, we focus in this review on the involvement of immune cell-nerve interactions in inflammatory bowel disease and irritable bowel syndrome. Firstly, the possible effects of enteric nerves, especially of the nonadrenergic and noncholinergic nerves, on the intestinal immune system and their possible role in the pathogenesis of chronic intestinal inflammatory diseases are described. Secondly, the possible effects of immunological factors, from the innate (chemokines and Toll-like receptors) as well as the adaptive (cytokines and immunoglobulins) immune system, on gastro-intestinal nerves and its potential role in the development of inflammatory bowel disease and irritable bowel syndrome are reviewed. investigations of receptor-mediated and intracellular signal pathways in neuro-immune interactions might help to develop more effective therapeutic approaches for chronic inflammatory intestinal diseases. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:361 / 374
页数:14
相关论文
共 182 条
[11]  
Bamias Giorgos, 2003, Curr Opin Investig Drugs, V4, P1279
[12]   Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease [J].
Banks, C ;
Bateman, A ;
Payne, R ;
Johnson, P ;
Sheron, N .
JOURNAL OF PATHOLOGY, 2003, 199 (01) :28-35
[13]   Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome [J].
Barbara, G ;
Stanghellini, V ;
De Giorgio, R ;
Cremon, C ;
Cottrell, GS ;
Santini, D ;
Pasquinelli, G ;
Morselli-Labate, AM ;
Grady, EF ;
Bunnett, NW ;
Collins, SM ;
Corinalidesi, R .
GASTROENTEROLOGY, 2004, 126 (03) :693-702
[14]   Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology [J].
Baumgart, Daniel C. ;
Carding, Simon R. .
LANCET, 2007, 369 (9573) :1627-1640
[15]  
BERNSTEIN CN, 1993, AM J GASTROENTEROL, V88, P908
[16]   Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors [J].
Bhangoo, Sonia ;
Ren, Dongjun ;
Miller, Richard J. ;
Henry, Kenneth J. ;
Lineswala, Jayana ;
Hamdouchi, Chafiq ;
Li, Baolin ;
Monahan, Patrick E. ;
Chan, David M. ;
Ripsch, Matthew S. ;
White, Fletcher A. .
MOLECULAR PAIN, 2007, 3
[17]   Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis [J].
Bitton, A ;
Peppercorn, MA ;
Antonioli, DA ;
Niles, JL ;
Shah, S ;
Bousvaros, A ;
Ransil, B ;
Wild, G ;
Cohen, A ;
Edwardes, MDD ;
Stevens, AC .
GASTROENTEROLOGY, 2001, 120 (01) :13-20
[18]   ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets [J].
Bizzarri, Cinzia ;
Beccari, Andrea Rosario ;
Bertini, Riccardo ;
Cavicchia, Michela Rita ;
Giorgini, Simona ;
Allegretti, Marcello .
PHARMACOLOGY & THERAPEUTICS, 2006, 112 (01) :139-149
[19]   Influence of topical rectal application of drugs on dextran sulfate-induced colitis in rats [J].
Bjorck, S ;
Jennische, E ;
Dahlstrom, A ;
Ahlman, H .
DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (04) :824-832
[20]   Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats [J].
Bourdu, S ;
Dapoigny, M ;
Chapuy, E ;
Artigue, F ;
Vasson, MP ;
Dechelotte, P ;
Bommelaer, G ;
Eschalier, A ;
Ardid, D .
GASTROENTEROLOGY, 2005, 128 (07) :1996-2008